Carlos Besses

4.3k total citations
78 papers, 1.8k citations indexed

About

Carlos Besses is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Carlos Besses has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Genetics, 34 papers in Hematology and 31 papers in Molecular Biology. Recurrent topics in Carlos Besses's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (49 papers), Kruppel-like factors research (27 papers) and Acute Myeloid Leukemia Research (17 papers). Carlos Besses is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (49 papers), Kruppel-like factors research (27 papers) and Acute Myeloid Leukemia Research (17 papers). Carlos Besses collaborates with scholars based in Spain, United Kingdom and Germany. Carlos Besses's co-authors include Alberto Álvarez‐Larrán, Beatríz Bellosillo, Francisco Cervantes, Jean‐Jacques Kiladjian, Françesc Solé, Lourdes Florensa, J Sans-Sabrafén, Juan Carlos Hernández‐Boluda, Martin Grießhammer and S Woessner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Surgical Pathology.

In The Last Decade

Carlos Besses

74 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Besses Spain 22 1.4k 919 845 525 227 78 1.8k
Rakhee Vaidya United States 13 1.6k 1.2× 1.3k 1.4× 897 1.1× 625 1.2× 282 1.2× 43 2.1k
Ester Pungolino Italy 16 1.6k 1.2× 1.4k 1.6× 864 1.0× 538 1.0× 196 0.9× 39 2.0k
C. Astori Italy 13 764 0.6× 574 0.6× 471 0.6× 281 0.5× 260 1.1× 22 1.1k
Cesare Astori Italy 14 735 0.5× 497 0.5× 472 0.6× 237 0.5× 224 1.0× 29 1.0k
Chiara Elena Italy 22 2.0k 1.5× 1.6k 1.8× 1.3k 1.6× 762 1.5× 82 0.4× 61 2.4k
Margherita Maffioli Italy 20 2.5k 1.8× 2.5k 2.7× 1.4k 1.7× 729 1.4× 126 0.6× 61 3.1k
Jean‐Didier Rain France 16 808 0.6× 595 0.6× 385 0.5× 325 0.6× 345 1.5× 32 1.5k
Eva Löfvenberg Sweden 18 813 0.6× 988 1.1× 362 0.4× 166 0.3× 229 1.0× 32 1.4k
Lisa Pieri Italy 21 2.2k 1.6× 1.7k 1.9× 1.5k 1.8× 939 1.8× 69 0.3× 58 2.6k
Kebede H. Begna United States 27 2.8k 2.0× 2.6k 2.9× 1.7k 2.0× 934 1.8× 102 0.4× 147 3.6k

Countries citing papers authored by Carlos Besses

Since Specialization
Citations

This map shows the geographic impact of Carlos Besses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Besses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Besses more than expected).

Fields of papers citing papers by Carlos Besses

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Besses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Besses. The network helps show where Carlos Besses may publish in the future.

Co-authorship network of co-authors of Carlos Besses

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Besses. A scholar is included among the top collaborators of Carlos Besses based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Besses. Carlos Besses is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tapper, William, Joannah Score, Andrew Chase, et al.. (2025). Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22 / CD40. Blood. 146(26). 3228–3233.
2.
Birgegård, Gunnar, Yasin Folkvaljon, Hans Garmo, et al.. (2016). Rate Of Malignant Transformation In High Risk Et During 5 Years Of Follow-Up Of Cytoreductive Therapy. Haematologica. 101. 96–96. 1 indexed citations
3.
Birgegård, Gunnar, Carlos Besses, Martin Grießhammer, et al.. (2015). RISK FACTORS FOR THROMBOHEMORRHAGIC AND TRANSFORMATION EVENTS IN 3649 HIGH-RISK PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA : RESULTS FROM THE PROSPECTIVE LONG-TERM OBSERVATIONAL EXELS STUDY. Haematologica. 100(3). 160–161. 1 indexed citations
4.
Raya, José María, Santiago Montes‐Moreno, Agustín Acevedo, et al.. (2014). Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report. Journal of Clinical Pathology. 67(7). 620–625. 9 indexed citations
5.
Besses, Carlos, W. Zeller, Alberto Álvarez‐Larrán, et al.. (2012). Pharmacokinetics and tolerability of anagrelide hydrochloride in young (18 50 years) and elderly (? 65 years) patients with essential thrombocythemia. International Journal of Clinical Pharmacology and Therapeutics. 50(11). 787–796. 8 indexed citations
6.
Gimeno, Eva, Miquel Gómez, Juan R. González, et al.. (2011). NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma. Leukemia Research. 35(6). 715–720. 31 indexed citations
7.
Besses, Carlos, Alberto Álvarez‐Larrán, Luz Martínez‐Avilés, et al.. (2011). Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients. British Journal of Haematology. 152(4). 413–419. 17 indexed citations
8.
Martínez‐Avilés, Luz, et al.. (2011). TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms. Annals of Hematology. 91(4). 533–541. 38 indexed citations
9.
Álvarez‐Larrán, Alberto, Francisco Cervantes, Arturo Pereira, et al.. (2010). Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood. 116(8). 1205–1210. 164 indexed citations
10.
Giralt, M, L Hernández-Nieto, Carmen Burgaleta, et al.. (2009). Análisis retrospectivo de la eficacia y la tolerabilidad de anagrelida en pacientes con trombocitemia esencial: registro español de trombocitemia esencial. Medicina Clínica. 133(3). 86–90. 1 indexed citations
11.
Salar, Antonio, Blanca Sánchez‐González, Alberto Álvarez‐Larrán, et al.. (2009). NT-ProBNP prediction of major chemotherapy-related toxicity and death in lymphoma patients. Journal of Clinical Oncology. 27(15_suppl). 9569–9569. 2 indexed citations
12.
Puigdecanet, Eulàlia, Blanca Espinet, Juan José Lozano, et al.. (2008). Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia. Leukemia. 22(7). 1368–1376. 25 indexed citations
13.
Abella, Eugènia, Javier Gimeno, Carmen Pedro, et al.. (2008). Diarrheic syndrome as a clinical sign of intestinal infiltration in progressive B-cell chronic lymphocytic leukemia. Leukemia Research. 33(1). 159–161. 6 indexed citations
14.
Barosi, Giovanni, Carlos Besses, Gunnar Birgegård, et al.. (2006). A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group. Leukemia. 21(2). 277–280. 80 indexed citations
15.
Salar, Antonio, Marta Cervera, Carmen Pedro, et al.. (2006). Rapid infusion of rituximab with or without steroid‐containing chemotherapy: 1‐yr experience in a single institution. European Journal Of Haematology. 77(4). 338–340. 36 indexed citations
16.
Besses, Carlos, Francisco Cervantes, Arturo Pereira, et al.. (1999). Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia. 13(2). 150–154. 143 indexed citations
17.
Florensa, Lourdes, S Woessner, Carlos Besses, Françesc Solé, & J Sans-Sabrafén. (1994). Congenital dyserythropoietic anemia type II: Morphological characterization of the erythroid colonies (BFU-E) from the bone marrow and peripheral blood of two patients. Annals of Hematology. 69(2). 57–59. 3 indexed citations
18.
Solé, Françesc, S Woessner, P. Aguado, et al.. (1994). Burkitt's type translocation in multiple myeloma. Leukemia Research. 18(9). 671–673. 6 indexed citations
19.
20.
Solé, Françesc, et al.. (1991). Isochromosome 14q in myeloid dysplastic disorder. Cancer Genetics and Cytogenetics. 54(1). 133–134. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rakhee Vaidya Breakdown of academic impact, for papers by Ester Pungolino Breakdown of academic impact, for papers by C. Astori Breakdown of academic impact, for papers by Cesare Astori Breakdown of academic impact, for papers by Chiara Elena Breakdown of academic impact, for papers by Margherita Maffioli Breakdown of academic impact, for papers by Jean‐Didier Rain Breakdown of academic impact, for papers by Eva Löfvenberg Breakdown of academic impact, for papers by Lisa Pieri Breakdown of academic impact, for papers by Kebede H. Begna
Rankless by CCL
2026